Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1Университет им. Давида Бен-Гуриона в Негеве. 8410501, Израиль, Беер-Шева; 2ФГБОУ ВО «Ставропольский государственный медицинский университет» Минздрава России. 355017, Россия, Ставрополь, ул. Мира, д. 310 yubykov@gmail.com
Список исп. литературыСкрыть список 1. Александровский Ю.А. Психиатрия и психофармакотерапия. Избранные лекции и выступления. М.: ГЭОТАР-МЕД, 2003. / Aleksandrovskii Yu.A. Psikhiatriia i psikhofarmakoterapiia. Izbrannye lektsii i vystupleniia. M.: GEOTAR-MED, 2003. [in Russian] 2. Брюханов А.В. Оптимизация ресоциализации пациентов с психической зависимостью от психоактивных веществ на фоне применения антидепрессанта Триттико (Тразодон). Вестн. Ассоциации психиатров Украины. 2013; 5: 29–32. / Bryukhanov A.V. Optimizatsiia resotsializatsii patsientov s psikhicheskoi zavisimost'iu ot psikhoaktivnykh veshchestv na fone primeneniia antidepressanta Trittiko (Trazodon). Vestn. Assotsiatsii psikhiatrov Ukrainy. 2013; 5: 29–32. [in Russian] 3. Бурчинский С.Г. Тразодон и его возможности в лечении депрессивных расстройств (Обзор литературы). Укр. вісник психоневрології. 2011; 19 (4): 57–60. / Burchinskii S.G. Trazodon i ego vozmozhnosti v lechenii depressivnykh rasstroistv (Obzor literatury). Ukr. vіsnik psikhonevrologії. 2011; 19 (4): 57–60. [in Russian] 4. Забозлаева И.В., Малинина Е.В. Применение Тразодона (Триттико) в лечении депрессивных расстройств в детском возрасте. Уральский мед. журн. 2011; 11 (89): 18–21. / Zabozlaeva I.V., Malinina E.V. Primenenie Trazodona (Trittiko) v lechenii depressivnykh rasstroistv v detskom vozraste. Ural'skii med. zhurn. 2011; 11 (89): 18–21. [in Russian] 5. Крупицкий Е.М., Бураков А.М., Ериш С.М. и др. Применение антидепрессанта Тразодона для лечения постабстинентных расстройств у больных героиновой наркоманией. Психиатрия. 2009; 1 (37): 62–6. / Krupitskii E.M., Burakov A.M., Erish S.M. i dr. Primenenie antidepressanta Trazodona dlia lecheniia postabstinentnykh rasstroistv u bol'nykh geroinovoi narkomaniei. Psikhiatriia. 2009; 1 (37): 62–6. [in Russian] 6. Фрешска Э. Многофункциональный механизм действия Тразодона и область его клинического применения. Вестн. Ассоциации психиатров Украины. 2013; 1: 14–8. / Freshska E. Mnogofunktsional'nyi mekhanizm deistviia Trazodona i oblast' ego klinicheskogo primeneniia. Vestn. Assotsiatsii psikhiatrov Ukrainy. 2013; 1: 14–8. [in Russian] 7. Чабан О.С., Хаустова Е.А., Безшейко В.Г. Данные открытого в параллельных группах активно-контролированного постмаркетингового исследования эффективности и безопасности препарата Триттико в сравнении со стандартной терапией пациентов с непсихотическими депрессивными расстройствами. Новости мед. и фармации. 2015; 2 (531): 7–14. / Chaban O.S., Khaustova E.A., Bezsheiko V.G. Dannye otkrytogo v parallel'nykh gruppakh aktivno-kontrolirovannogo postmarketingovogo issledovaniia effektivnosti i bezopasnosti preparata Trittiko v sravnenii so standartnoi terapiei patsientov s nepsikhoticheskimi depressivnymi rasstroistvami. Novosti med. i farmatsii. 2015; 2 (531): 7–14. [in Russian] 8. Altamura AC, Mauri MC, Rudas N et al. Clinical activity and tolerability of trazodone, mianserin, and amitriptyline in elderly subjects with major depression: a controlled multicenter trial. Clin Neuropharmacol 1989; 12 (Suppl. 1): S25–33 (S4–7). 9. Ansseau M, De Roeck J. Trazodone in benzodiazepine dependence. J Clin Psychiatry 1993; 54 (5): 189–91. 10. Ather SA, Ankier SI, Middleton RS. A double-blind evaluation of trazodone in the treatment of depression in the elderly. Br J Clin Pract 1985; 39 (5): 192–9. 11. Baxter LR Jr. Two cases of obsessive-compulsive disorder with depression responsive to trazodone. J Nerv Ment Dis. 1985; 173 (7): 432–3. 12. Beasley CM Jr, Dornseif BE, Pultz JA et al. Fluoxetine versus trazodone: efficacy and activating-sedating effects. J Clin Psychiatry 1991; 52 (7): 294–9. 13. Borras L, de Timary P, Constant EL et al. Successful treatment of alcohol withdrawal with trazodone. Pharmacopsychiatry 2006; 39 (6): 232. 14. Bossini L, Coluccia A, Casolaro I et al. Off-Label Trazodone Prescription: Evidence, Benefits and Risks. Curr Pharm Des 2015; 21 (23): 3343–51. 15. Buoli M, Rovera C, Pozzoli SM et al. Is trazodone more effective than clomipramine in major depressed outpatients? A single-blind study with intravenous and oral administration. CNS Spectr 2017; 30: 1–7. 16. Charney DS, Woods SW, Goodman WK et al. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone. J Clin Psychiatry 1986; 47 (12): 580–6. 17. Crome P, Ali C. Clinical features and management of self-poisoning with newer antidepressants. Med Toxicol 1986; 1: 411–20. 18. Cunningham LA, Borison RL, Carman JS et al. A comparison of venlafaxine, trazodone, and placebo in major depression. J Clin Psychopharmacol 1994; 14 (2): 99–106. 19. Cusack B, Nelson A, Richelson E. Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology Berl 1994; 114 (4): 559–65. 20. De Jonghe F, Swinkels JA. The safety of antidepressants. Drugs 1992; 43 (Suppl. 2): 40–6. 21. Fagiolini A, Comandini A, Catena Dell'Osso M, Kasper S. Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs 2012; 26 (12): 1033–49. 22. Falk WE, Rosenbaum JF, Otto MW et al. Fluoxetine versus trazodone in depressed geriatric patients. J Geriatr Psychiatry Neurol 1989; 2 (4): 208–14. 23. Feighner JP, Boyer WF. Overview of USA controlled trials of trazodone in clinical depression. Psychopharmacology 1988; 95: S50–S53. 24. Friedmann PD, Herman DS, Freedman S et al. Treatment of sleep disturbance in alcohol recovery: a national survey of addiction medicine physicians. J Addict Dis 2003; 22: 91–103. 25. Gale CK. The treatment of generalised anxiety disorder: a systematic review. Panminerva Med 2002; 44 (4): 283–6. 26. Gerner R, Estabrook W, Steuer J, Jarvik L. Treatment of geriatric depression with trazodone, imipramine, and placebo: a double-blind study. J Clin Psychiatry 1980; 41 (6): 216–20. 27. Hermesh H, Aizenberg D, Munitz H. Trazodone treatment in clomipramine-resistant obsessive-compulsive disorder. Clin Neuropharmacol 1990; 13 (4): 322–8. 28. Hertzberg MA, Feldman ME, Beckham JC, Davidson JR. Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design. J Clin Psychopharmacol 1996; 16 (4): 294–8. 29. Janiri L, Hadjichristos A, Buonanno A et al. Adjuvant trazodone in the treatment of alcoholism: an open study. Alcohol Alcohol 1998; 33 (4): 362–5. 30. Kasper S, Olivieri L, Di Loreto G, Dionisio P. A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder. Curr Med Res Opin 2005; 21 (8): 1139–46. 31. Kasper S, Olivieri L, Di Loreto G, Dionisio P. A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder. Curr Med Res Opin 2005; 21 (8): 1139–46. 32. Le Bon O, Murphy JR, Staner L et al. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations. J Clin Psychopharmacol 2003; 23 (4): 377–83. 33. Lopes R, Alves JC, Rego RG. Trazodone Addition to Paroxetine and Mirtazapine in a Patient with Treatment-Resistant Depression: The Pros and Cons of Combining Three Antidepressants. Case Rep Med 2016; 2016: 5362485. 34. Mavissakalian M, Perel J, Bowler K, Dealy R. Trazodone in the treatment of panic disorder and agoraphobia with panic attacks. Am J Psychiatry 1987; 144 (6): 785–7. 35. Munizza C, Olivieri L, Di Loreto G, Dionisio P. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder. Curr Med Res Opin 2006; 22 (9): 1703–13. 36. Owens MJ, Morgan WN, Plott SJ, Nemeroff CB. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 1997; 283 (3): 1305–22. 37. Papakostas GI, Fava M. A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Eur Psychiatry 2007; 22 (7): 444–7. 38. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Arlington: American Psychiatric Association, 2010. 39. Rickels K, Downing R, Schweizer E, Hassman H. Antidepressants for the treatment of generalized anxiety disorder: a placebo-controlled comparison of imipramine, trazodone, and diazepam. Arch Gen Psychiatry 1993; 50 (11): 884–95. 40. Rocha FF, Correa H, Lage NV. Addition of trazodone to sertraline: a probable synergistic action in a case of obsessive-compulsive disorder. Rev Bras Psiquiatr 2007; 29 (4): 381–2. 41. Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P et al. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26 (2): 249–60. 42. Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P et al. Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone. Neuropsychobiol 2001; 44 (3): 139–49. 43. Shin JJ, Saadabadi A. Trazodone. Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing, 2018. 44. Stahl SM. Mechanism of action of trazodone: a multifunctional drug. CNS Spectr 2009; 14 (10): 536–46. 45. Stahl SM. Stahl’s essential psychopharmacology: neuroscientific basis and practical applications. Cambridge university press, 2013. 46. Sultan MA, Courtney DB. Adjunctive Trazodone and Depression Outcome in Adolescents Treated with Serotonin Re-uptake Inhibitors. J Can Acad Child Adolesc Psychiatry 2017; 26 (3): 233–40. 47. Warner MD, Dorn MR, Peabody CA. Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares. Pharmacopsychiatry 2001; 34 (4): 128–31. 48. Weisler RH, Johnston JA, Lineberry CG et al. Comparison of bupropion and trazodone for the treatment of major depression. J Clin Psychopharmacol 1994; 14 (3): 170–9.